Valuation check: NDRAW's PEG ratio is -2.12, below the Technology sector average of 12.49.
Get informed when a big investor buys or sells
+ Follow-2.12
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
ENDRA Life Sciences- Warrants (12/05/2022) (NDRAW) currently reports a PEG ratio of -2.12. That is below the Technology sector average of 12.49. Use the charts on this page to explore ENDRA Life Sciences- Warrants (12/05/2022)'s PEG ratio history and peer comparisons.
ENDRA Life Sciences- Warrants (12/05/2022)'s PEG ratio of -2.12 is lower than the Technology sector average of 12.49. That is roughly 117.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The PEG ratio is a valuation multiple that relates ENDRA Life Sciences- Warrants (12/05/2022)'s market price to a fundamental measure such as earnings, sales, or book value. At -2.12, NDRAW can look expensive or cheap only in context — versus its own history, growth rate, and Technology peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current PEG ratio of -2.12, then check the historical chart for trend and the peer comparison chart for relative positioning. The Technology average is 12.49. From there, open related valuation or income-statement pages for ENDRA Life Sciences- Warrants (12/05/2022), and consider following NDRAW for alerts when major investors trade the stock.
ENDRA Life Sciences- Warrants (12/05/2022) is classified in the Technology sector. On PEG ratio, it currently shows -2.12 versus a sector average near 12.49. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing NDRAW with unrelated industries.